Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119452) titled 'Phase II clinical trial of preoperative neoadjuvant radioimmunotherapy combined with the standard STUPP regimen in the treatment of glioblastoma' on Feb. 27.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Sun Yat-sen University Cancer Center

Condition: Glioblastoma

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-03-01

Target Sample Size: Experimental group:28;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=310524

Published by HT Digital Content Services with permission from Health Daily Digest...